Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 24 of 169 entries
Sorted by: Best Match Show Resources per page
Common terms.

Maryland medicine : MM : a publication of MEDCHI, the Maryland State Medical Society

Gershen BJ.
PMID: 21657180
Md Med. 2011;12(1):32-3.

No abstract available.

Cite
Gershen BJ. Common terms. Md Med. 2011;12(1):32-3
Gershen, B. J. (2011). Common terms. Maryland medicine : MM : a publication of MEDCHI, the Maryland State Medical Society, 12(1), 32-3.
Gershen, Barton J. "Common terms." Maryland medicine : MM : a publication of MEDCHI, the Maryland State Medical Society vol. 12,1 (2011): 32-3.
Gershen BJ. Common terms. Md Med. 2011;12(1):32-3. PMID: 21657180.
Copy Download .nbib Format: NLM
Radiofrequency Ablation Versus Antiarrhythmic Drug Therapy for Atrial Fibrillation: Meta-Analysis of Quality of Life, Morbidity, and Mortality.

JACC. Clinical electrophysiology

Siontis KC, Ioannidis JPA, Katritsis GD, Noseworthy PA, Packer DL, Hummel JD, Jais P, Krittayaphong R, Mont L, Morillo CA, Nielsen JC, Oral H, Pappone C, Santinelli V, Weerasooriya R, Wilber DJ, Gersh BJ, Josephson ME, Katritsis DG.
PMID: 29766867
JACC Clin Electrophysiol. 2016 Apr;2(2):170-180. doi: 10.1016/j.jacep.2015.10.003. Epub 2015 Nov 10.

OBJECTIVES: The aim of this study was to perform a collaborative meta-analysis of published and unpublished quality-of-life, morbidity, and mortality data from randomized controlled trial comparisons of radiofrequency ablation (RFA) and antiarrhythmic drug therapy (AAD) in symptomatic atrial fibrillation.BACKGROUND:...

Cite
Siontis KC, Ioannidis JPA, Katritsis GD, et al. Radiofrequency Ablation Versus Antiarrhythmic Drug Therapy for Atrial Fibrillation: Meta-Analysis of Quality of Life, Morbidity, and Mortality. JACC Clin Electrophysiol. 2015;2(2):170-180doi: 10.1016/j.jacep.2015.10.003.
Siontis, K. C., Ioannidis, J. P. A., Katritsis, G. D., Noseworthy, P. A., Packer, D. L., Hummel, J. D., Jais, P., Krittayaphong, R., Mont, L., Morillo, C. A., Nielsen, J. C., Oral, H., Pappone, C., Santinelli, V., Weerasooriya, R., Wilber, D. J., Gersh, B. J., Josephson, M. E., & Katritsis, D. G. (2016). Radiofrequency Ablation Versus Antiarrhythmic Drug Therapy for Atrial Fibrillation: Meta-Analysis of Quality of Life, Morbidity, and Mortality. JACC. Clinical electrophysiology, 2(2), 170-180. https://doi.org/10.1016/j.jacep.2015.10.003
Siontis, Konstantinos C, et al. "Radiofrequency Ablation Versus Antiarrhythmic Drug Therapy for Atrial Fibrillation: Meta-Analysis of Quality of Life, Morbidity, and Mortality." JACC. Clinical electrophysiology vol. 2,2 (2016): 170-180. doi: https://doi.org/10.1016/j.jacep.2015.10.003
Siontis KC, Ioannidis JPA, Katritsis GD, Noseworthy PA, Packer DL, Hummel JD, Jais P, Krittayaphong R, Mont L, Morillo CA, Nielsen JC, Oral H, Pappone C, Santinelli V, Weerasooriya R, Wilber DJ, Gersh BJ, Josephson ME, Katritsis DG. Radiofrequency Ablation Versus Antiarrhythmic Drug Therapy for Atrial Fibrillation: Meta-Analysis of Quality of Life, Morbidity, and Mortality. JACC Clin Electrophysiol. 2016 Apr;2(2):170-180. doi: 10.1016/j.jacep.2015.10.003. Epub 2015 Nov 10. PMID: 29766867.
Copy Download .nbib Format: NLM
On the Pearls and Perils of Sub-Subspecialization.

The American journal of medicine

Oren O, Gersh BJ, Bhatt DL.
PMID: 31369725
Am J Med. 2020 Feb;133(2):158-159. doi: 10.1016/j.amjmed.2019.06.052. Epub 2019 Jul 30.

No abstract available.

Cite
Oren O, Gersh BJ, Bhatt DL. On the Pearls and Perils of Sub-Subspecialization. Am J Med. 2019;133(2):158-159doi: 10.1016/j.amjmed.2019.06.052.
Oren, O., Gersh, B. J., & Bhatt, D. L. (2020). On the Pearls and Perils of Sub-Subspecialization. The American journal of medicine, 133(2), 158-159. https://doi.org/10.1016/j.amjmed.2019.06.052
Oren, Ohad, et al. "On the Pearls and Perils of Sub-Subspecialization." The American journal of medicine vol. 133,2 (2020): 158-159. doi: https://doi.org/10.1016/j.amjmed.2019.06.052
Oren O, Gersh BJ, Bhatt DL. On the Pearls and Perils of Sub-Subspecialization. Am J Med. 2020 Feb;133(2):158-159. doi: 10.1016/j.amjmed.2019.06.052. Epub 2019 Jul 30. PMID: 31369725.
Copy Download .nbib Format: NLM
Baseline Demographics, Safety, and Patient Acceptance of an Insertable Cardiac Monitor for Atrial Fibrillation Screening: The REVEAL-AF Study.

Journal of atrial fibrillation

Conti S, Reiffel JA, Gersh BJ, Kowey PR, Wachter R, Halperin JL, Kaplon RE, Pouliot E, Verma A.
PMID: 29250279
J Atr Fibrillation. 2017 Feb 28;9(5):1551. doi: 10.4022/jafib.1551. eCollection 2017.

Given the high prevalence and risk of stroke associated with atrial fibrillation (AF), detection strategies have important public health implications. The ongoing prospective, single-arm, open-label, multicenter REVEAL AF trial is evaluating the incidence of previously undetected AF using an...

Cite
Conti S, Reiffel JA, Gersh BJ, et al. Baseline Demographics, Safety, and Patient Acceptance of an Insertable Cardiac Monitor for Atrial Fibrillation Screening: The REVEAL-AF Study. J Atr Fibrillation. 2017;9(5):1551doi: 10.4022/jafib.1551.
Conti, S., Reiffel, J. A., Gersh, B. J., Kowey, P. R., Wachter, R., Halperin, J. L., Kaplon, R. E., Pouliot, E., & Verma, A. (2017). Baseline Demographics, Safety, and Patient Acceptance of an Insertable Cardiac Monitor for Atrial Fibrillation Screening: The REVEAL-AF Study. Journal of atrial fibrillation, 9(5), 1551. https://doi.org/10.4022/jafib.1551
Conti, Sergio, et al. "Baseline Demographics, Safety, and Patient Acceptance of an Insertable Cardiac Monitor for Atrial Fibrillation Screening: The REVEAL-AF Study." Journal of atrial fibrillation vol. 9,5 (2017): 1551. doi: https://doi.org/10.4022/jafib.1551
Conti S, Reiffel JA, Gersh BJ, Kowey PR, Wachter R, Halperin JL, Kaplon RE, Pouliot E, Verma A. Baseline Demographics, Safety, and Patient Acceptance of an Insertable Cardiac Monitor for Atrial Fibrillation Screening: The REVEAL-AF Study. J Atr Fibrillation. 2017 Feb 28;9(5):1551. doi: 10.4022/jafib.1551. eCollection 2017. PMID: 29250279; PMCID: PMC5673395.
Copy Download .nbib Format: NLM
A case-series study to explore the efficacy of foot orthoses in treating first metatarsophalangeal joint pain.

Journal of foot and ankle research

Welsh BJ, Redmond AC, Chockalingam N, Keenan AM.
PMID: 20799935
J Foot Ankle Res. 2010 Aug 27;3:17. doi: 10.1186/1757-1146-3-17.

BACKGROUND: First metatarsophalangeal (MTP) joint pain is a common foot complaint which is often considered to be a consequence of altered mechanics. Foot orthoses are often prescribed to reduce 1st MTP joint pain with the aim of altering dorsiflexion...

Cite
Welsh BJ, Redmond AC, Chockalingam N, et al. A case-series study to explore the efficacy of foot orthoses in treating first metatarsophalangeal joint pain. J Foot Ankle Res. 2010;3:17doi: 10.1186/1757-1146-3-17.
Welsh, B. J., Redmond, A. C., Chockalingam, N., & Keenan, A. M. (2010). A case-series study to explore the efficacy of foot orthoses in treating first metatarsophalangeal joint pain. Journal of foot and ankle research, 317. https://doi.org/10.1186/1757-1146-3-17
Welsh, Brian J, et al. "A case-series study to explore the efficacy of foot orthoses in treating first metatarsophalangeal joint pain." Journal of foot and ankle research vol. 3 (2010): 17. doi: https://doi.org/10.1186/1757-1146-3-17
Welsh BJ, Redmond AC, Chockalingam N, Keenan AM. A case-series study to explore the efficacy of foot orthoses in treating first metatarsophalangeal joint pain. J Foot Ankle Res. 2010 Aug 27;3:17. doi: 10.1186/1757-1146-3-17. PMID: 20799935; PMCID: PMC2939594.
Copy Download .nbib Format: NLM
Association of Body Mass Index With Care and Outcomes in Patients With Atrial Fibrillation: Results From the ORBIT-AF Registry.

JACC. Clinical electrophysiology

Pandey A, Gersh BJ, McGuire DK, Shrader P, Thomas L, Kowey PR, Mahaffey KW, Hylek E, Sun S, Burton P, Piccini J, Peterson E, Fonarow GC.
PMID: 29766895
JACC Clin Electrophysiol. 2016 Jun;2(3):355-363. doi: 10.1016/j.jacep.2015.12.001. Epub 2015 Dec 09.

OBJECTIVES: This study sought to determine the association between body mass index (BMI) and clinical outcomes among patients with prevalent atrial fibrillation (AF).BACKGROUND: Higher BMI is an independent risk factor for incident AF. However, its impact on management strategies...

Cite
Pandey A, Gersh BJ, McGuire DK, et al. Association of Body Mass Index With Care and Outcomes in Patients With Atrial Fibrillation: Results From the ORBIT-AF Registry. JACC Clin Electrophysiol. 2015;2(3):355-363doi: 10.1016/j.jacep.2015.12.001.
Pandey, A., Gersh, B. J., McGuire, D. K., Shrader, P., Thomas, L., Kowey, P. R., Mahaffey, K. W., Hylek, E., Sun, S., Burton, P., Piccini, J., Peterson, E., & Fonarow, G. C. (2016). Association of Body Mass Index With Care and Outcomes in Patients With Atrial Fibrillation: Results From the ORBIT-AF Registry. JACC. Clinical electrophysiology, 2(3), 355-363. https://doi.org/10.1016/j.jacep.2015.12.001
Pandey, Ambarish, et al. "Association of Body Mass Index With Care and Outcomes in Patients With Atrial Fibrillation: Results From the ORBIT-AF Registry." JACC. Clinical electrophysiology vol. 2,3 (2016): 355-363. doi: https://doi.org/10.1016/j.jacep.2015.12.001
Pandey A, Gersh BJ, McGuire DK, Shrader P, Thomas L, Kowey PR, Mahaffey KW, Hylek E, Sun S, Burton P, Piccini J, Peterson E, Fonarow GC. Association of Body Mass Index With Care and Outcomes in Patients With Atrial Fibrillation: Results From the ORBIT-AF Registry. JACC Clin Electrophysiol. 2016 Jun;2(3):355-363. doi: 10.1016/j.jacep.2015.12.001. Epub 2015 Dec 09. PMID: 29766895.
Copy Download .nbib Format: NLM
Association of Feeding Evaluation With Frenotomy Rates in Infants With Breastfeeding Difficulties.

JAMA otolaryngology-- head & neck surgery

Caloway C, Hersh CJ, Baars R, Sally S, Diercks G, Hartnick CJ.
PMID: 31294774
JAMA Otolaryngol Head Neck Surg. 2019 Sep 01;145(9):817-822. doi: 10.1001/jamaoto.2019.1696.

IMPORTANCE: Inpatient surgical release of lingual frenulums rose 10-fold between 1997 and 2012 despite insufficient evidence that frenotomy for ankyloglossia is associated with improvements in breastfeeding. Clear indications for surgical release remain murky, and best practice guidelines have yet...

Cite
Caloway C, Hersh CJ, Baars R, et al. Association of Feeding Evaluation With Frenotomy Rates in Infants With Breastfeeding Difficulties. JAMA Otolaryngol Head Neck Surg. 2019;145(9):817-822doi: 10.1001/jamaoto.2019.1696.
Caloway, C., Hersh, C. J., Baars, R., Sally, S., Diercks, G., & Hartnick, C. J. (2019). Association of Feeding Evaluation With Frenotomy Rates in Infants With Breastfeeding Difficulties. JAMA otolaryngology-- head & neck surgery, 145(9), 817-822. https://doi.org/10.1001/jamaoto.2019.1696
Caloway, Christen, et al. "Association of Feeding Evaluation With Frenotomy Rates in Infants With Breastfeeding Difficulties." JAMA otolaryngology-- head & neck surgery vol. 145,9 (2019): 817-822. doi: https://doi.org/10.1001/jamaoto.2019.1696
Caloway C, Hersh CJ, Baars R, Sally S, Diercks G, Hartnick CJ. Association of Feeding Evaluation With Frenotomy Rates in Infants With Breastfeeding Difficulties. JAMA Otolaryngol Head Neck Surg. 2019 Sep 01;145(9):817-822. doi: 10.1001/jamaoto.2019.1696. PMID: 31294774; PMCID: PMC6624821.
Copy Download .nbib Format: NLM
Accessing low-oxidation state taxanes: is taxadiene-4(5)-epoxide on the taxol biosynthetic pathway?.

Chemical science

Barton NA, Marsh BJ, Lewis W, Narraidoo N, Seymour GB, Fray R, Hayes CJ.
PMID: 29997802
Chem Sci. 2016 May 01;7(5):3102-3107. doi: 10.1039/c5sc03463a. Epub 2016 Jan 26.

We have shown for the first time that taxadiene (

Cite
Barton NA, Marsh BJ, Lewis W, et al. Accessing low-oxidation state taxanes: is taxadiene-4(5)-epoxide on the taxol biosynthetic pathway?. Chem Sci. 2016;7(5):3102-3107doi: 10.1039/c5sc03463a.
Barton, N. A., Marsh, B. J., Lewis, W., Narraidoo, N., Seymour, G. B., Fray, R., & Hayes, C. J. (2016). Accessing low-oxidation state taxanes: is taxadiene-4(5)-epoxide on the taxol biosynthetic pathway?. Chemical science, 7(5), 3102-3107. https://doi.org/10.1039/c5sc03463a
Barton, Naomi A, et al. "Accessing low-oxidation state taxanes: is taxadiene-4(5)-epoxide on the taxol biosynthetic pathway?." Chemical science vol. 7,5 (2016): 3102-3107. doi: https://doi.org/10.1039/c5sc03463a
Barton NA, Marsh BJ, Lewis W, Narraidoo N, Seymour GB, Fray R, Hayes CJ. Accessing low-oxidation state taxanes: is taxadiene-4(5)-epoxide on the taxol biosynthetic pathway?. Chem Sci. 2016 May 01;7(5):3102-3107. doi: 10.1039/c5sc03463a. Epub 2016 Jan 26. PMID: 29997802; PMCID: PMC6005263.
Copy Download .nbib Format: NLM
Analysis of HBsAg Immunocomplexes and cccDNA Activity During and Persisting After NAP-Based Therapy.

Hepatology communications

Bazinet M, Anderson M, Pântea V, Placinta G, Moscalu I, Cebotarescu V, Cojuhari L, Jimbei P, Iarovoi L, Smesnoi V, Musteata T, Jucov A, Dittmer U, Gersch J, Holzmayer V, Kuhns M, Cloherty G, Vaillant A.
PMID: 34558823
Hepatol Commun. 2021 Nov;5(11):1873-1887. doi: 10.1002/hep4.1767. Epub 2021 Jul 10.

Therapy with nucleic acid polymers (NAPs), tenofovir disoproxil fumarate (TDF), and pegylated interferon (pegIFN) achieve high rates of HBsAg loss/seroconversion and functional cure in chronic hepatitis B virus (HBV) infection. The role of hepatitis B surface antigen (HBsAg) seroconversion...

Cite
Bazinet M, Anderson M, Pântea V, et al. Analysis of HBsAg Immunocomplexes and cccDNA Activity During and Persisting After NAP-Based Therapy. Hepatol Commun. 2021;5(11):1873-1887doi: 10.1002/hep4.1767.
Bazinet, M., Anderson, M., Pântea, V., Placinta, G., Moscalu, I., Cebotarescu, V., Cojuhari, L., Jimbei, P., Iarovoi, L., Smesnoi, V., Musteata, T., Jucov, A., Dittmer, U., Gersch, J., Holzmayer, V., Kuhns, M., Cloherty, G., & Vaillant, A. (2021). Analysis of HBsAg Immunocomplexes and cccDNA Activity During and Persisting After NAP-Based Therapy. Hepatology communications, 5(11), 1873-1887. https://doi.org/10.1002/hep4.1767
Bazinet, Michel, et al. "Analysis of HBsAg Immunocomplexes and cccDNA Activity During and Persisting After NAP-Based Therapy." Hepatology communications vol. 5,11 (2021): 1873-1887. doi: https://doi.org/10.1002/hep4.1767
Bazinet M, Anderson M, Pântea V, Placinta G, Moscalu I, Cebotarescu V, Cojuhari L, Jimbei P, Iarovoi L, Smesnoi V, Musteata T, Jucov A, Dittmer U, Gersch J, Holzmayer V, Kuhns M, Cloherty G, Vaillant A. Analysis of HBsAg Immunocomplexes and cccDNA Activity During and Persisting After NAP-Based Therapy. Hepatol Commun. 2021 Nov;5(11):1873-1887. doi: 10.1002/hep4.1767. Epub 2021 Jul 10. PMID: 34558823; PMCID: PMC8557319.
Copy Download .nbib Format: NLM
More DNA and RNA of HBV SP1 splice variants are detected in genotypes B and C at low viral replication.

Scientific reports

Luk KC, Gersch J, Harris BJ, Holzmayer V, Mbanya D, Sauleda S, Rodgers MA, Cloherty G.
PMID: 34903774
Sci Rep. 2021 Dec 13;11(1):23838. doi: 10.1038/s41598-021-03304-w.

HBV produces unspliced and spliced RNAs during replication. Encapsidated spliced RNA is converted into DNA generating defective virions that are detected in plasma and associated with HCC development. Herein we describe a quantitative real-time PCR detection of splice variant...

Cite
Luk KC, Gersch J, Harris BJ, et al. More DNA and RNA of HBV SP1 splice variants are detected in genotypes B and C at low viral replication. Sci Rep. 2021;11(1):23838doi: 10.1038/s41598-021-03304-w.
Luk, K. C., Gersch, J., Harris, B. J., Holzmayer, V., Mbanya, D., Sauleda, S., Rodgers, M. A., & Cloherty, G. (2021). More DNA and RNA of HBV SP1 splice variants are detected in genotypes B and C at low viral replication. Scientific reports, 11(1), 23838. https://doi.org/10.1038/s41598-021-03304-w
Luk, Ka-Cheung, et al. "More DNA and RNA of HBV SP1 splice variants are detected in genotypes B and C at low viral replication." Scientific reports vol. 11,1 (2021): 23838. doi: https://doi.org/10.1038/s41598-021-03304-w
Luk KC, Gersch J, Harris BJ, Holzmayer V, Mbanya D, Sauleda S, Rodgers MA, Cloherty G. More DNA and RNA of HBV SP1 splice variants are detected in genotypes B and C at low viral replication. Sci Rep. 2021 Dec 13;11(1):23838. doi: 10.1038/s41598-021-03304-w. PMID: 34903774; PMCID: PMC8668879.
Copy Download .nbib Format: NLM
Comparative effectiveness of oral anticoagulants in everyday practice.

Heart (British Cardiac Society)

Camm AJ, Fox KAA, Virdone S, Bassand JP, Fitzmaurice DA, Berchuck SI, Gersh BJ, Goldhaber SZ, Goto S, Haas S, Misselwitz F, Pieper KS, Turpie AGG, Verheugt FWA, Cappato R, Kakkar AK.
PMID: 33593994
Heart. 2021 Feb 16; doi: 10.1136/heartjnl-2020-318420. Epub 2021 Feb 16.

OBJECTIVES: This study evaluated the comparative effectiveness of vitamin K antagonists (VKAs), direct thrombin inhibitors (DTIs) and factor Xa inhibitors (FXaI) in patients with atrial fibrillation (AF) at risk of stroke in everyday practice.METHODS: Data from patients with AF...

Cite
Camm AJ, Fox KAA, Virdone S, et al. Comparative effectiveness of oral anticoagulants in everyday practice. Heart. 2021;doi: 10.1136/heartjnl-2020-318420.
Camm, A. J., Fox, K. A. A., Virdone, S., Bassand, J. P., Fitzmaurice, D. A., Berchuck, S. I., Gersh, B. J., Goldhaber, S. Z., Goto, S., Haas, S., Misselwitz, F., Pieper, K. S., Turpie, A. G. G., Verheugt, F. W. A., Cappato, R., Kakkar, A. K. (2021). Comparative effectiveness of oral anticoagulants in everyday practice. Heart (British Cardiac Society), . https://doi.org/10.1136/heartjnl-2020-318420
Camm, A John, et al. "Comparative effectiveness of oral anticoagulants in everyday practice." Heart (British Cardiac Society) vol. (2021). doi: https://doi.org/10.1136/heartjnl-2020-318420
Camm AJ, Fox KAA, Virdone S, Bassand JP, Fitzmaurice DA, Berchuck SI, Gersh BJ, Goldhaber SZ, Goto S, Haas S, Misselwitz F, Pieper KS, Turpie AGG, Verheugt FWA, Cappato R, Kakkar AK. Comparative effectiveness of oral anticoagulants in everyday practice. Heart. 2021 Feb 16; doi: 10.1136/heartjnl-2020-318420. Epub 2021 Feb 16. PMID: 33593994; PMCID: PMC8165153.
Copy Download .nbib Format: NLM
Safety and Efficacy of Flexible-Dose Deutetrabenazine in Children and Adolescents With Tourette Syndrome: A Randomized Clinical Trial.

JAMA network open

Jankovic J, Coffey B, Claassen DO, Jimenez-Shahed J, Gertz BJ, Garofalo EA, Stamler DA, Wieman M, Savola JM, Gordon MF, Alexander J, Barkay H, Harary E.
PMID: 34609495
JAMA Netw Open. 2021 Oct 01;4(10):e2128204. doi: 10.1001/jamanetworkopen.2021.28204.

IMPORTANCE: Tourette syndrome is a neurodevelopmental disorder characterized by childhood onset of motor and phonic tics; treatments for tics are associated with safety concerns. Deutetrabenazine is a selective vesicular monoamine transporter 2 inhibitor approved for the treatment of chorea...

Cite
Jankovic J, Coffey B, Claassen DO, et al. Safety and Efficacy of Flexible-Dose Deutetrabenazine in Children and Adolescents With Tourette Syndrome: A Randomized Clinical Trial. JAMA Netw Open. 2021;4(10):e2128204doi: 10.1001/jamanetworkopen.2021.28204.
Jankovic, J., Coffey, B., Claassen, D. O., Jimenez-Shahed, J., Gertz, B. J., Garofalo, E. A., Stamler, D. A., Wieman, M., Savola, J. M., Gordon, M. F., Alexander, J., Barkay, H., & Harary, E. (2021). Safety and Efficacy of Flexible-Dose Deutetrabenazine in Children and Adolescents With Tourette Syndrome: A Randomized Clinical Trial. JAMA network open, 4(10), e2128204. https://doi.org/10.1001/jamanetworkopen.2021.28204
Jankovic, Joseph, et al. "Safety and Efficacy of Flexible-Dose Deutetrabenazine in Children and Adolescents With Tourette Syndrome: A Randomized Clinical Trial." JAMA network open vol. 4,10 (2021): e2128204. doi: https://doi.org/10.1001/jamanetworkopen.2021.28204
Jankovic J, Coffey B, Claassen DO, Jimenez-Shahed J, Gertz BJ, Garofalo EA, Stamler DA, Wieman M, Savola JM, Gordon MF, Alexander J, Barkay H, Harary E. Safety and Efficacy of Flexible-Dose Deutetrabenazine in Children and Adolescents With Tourette Syndrome: A Randomized Clinical Trial. JAMA Netw Open. 2021 Oct 01;4(10):e2128204. doi: 10.1001/jamanetworkopen.2021.28204. PMID: 34609495; PMCID: PMC8493441.
Copy Download .nbib Format: NLM
Showing 13 to 24 of 169 entries